THREE YEARS SHOWS HIGH BARRIER TO RESISTANCE IS MAINTAINED IN ENTECAVIR-TREATED NUCLEOSIDE NAÏVE PATIENTS WHILE RESISTANCE EMERGENCE INCREASES OVER TIME IN LAMIVUDINE REFRACTORY PATIENTS

COLONNO, R.J., & ROSE, R.E.. (2006). THREE YEARS SHOWS HIGH BARRIER TO RESISTANCE IS MAINTAINED IN ENTECAVIR-TREATED NUCLEOSIDE NAIVE PATIENTS WHILE RESISTANCE EMERGENCE INCREASES OVER TIME IN LAMIVUDINE REFRACTORY PATIENTS. HEPATOLOGY, 44(SUPPL 1), 229-230. SID. https://sid.ir/paper/658840/en

COLONNO R.J., ROSE R.E.. THREE YEARS SHOWS HIGH BARRIER TO RESISTANCE IS MAINTAINED IN ENTECAVIR-TREATED NUCLEOSIDE NAIVE PATIENTS WHILE RESISTANCE EMERGENCE INCREASES OVER TIME IN LAMIVUDINE REFRACTORY PATIENTS. HEPATOLOGY[Internet]. 2006;44(SUPPL 1):229-230. Available from: https://sid.ir/paper/658840/en

R.J. COLONNO, and R.E. ROSE, “THREE YEARS SHOWS HIGH BARRIER TO RESISTANCE IS MAINTAINED IN ENTECAVIR-TREATED NUCLEOSIDE NAIVE PATIENTS WHILE RESISTANCE EMERGENCE INCREASES OVER TIME IN LAMIVUDINE REFRACTORY PATIENTS,” HEPATOLOGY, vol. 44, no. SUPPL 1, pp. 229–230, 2006, [Online]. Available: https://sid.ir/paper/658840/en